Hadassah

Hadassah Cancer Specialists Explore Link Between Colorectal Cancer and BRCA Mutations

Wednesday, Jul 11 2018

Looking further into the link between colorectal cancer and BRCA 1 and 2 genetic mutations, researchers from the Hadassah Medical Center’s Sharett Institute of Oncology, together with colleagues from Chaim Sheba Medical Center, analyzed data from 32 patients with lower gastrointestinal cancers. Nearly 63 percent of the patients were BRCA 1 carriers, and two of the patients also had anal cancer.

Though mucinous tumors are typically rare and are usually situated in the right side of the colon, carriers of the BRCA mutations were more than twice as likely to have mucinous tumors than non-BRCA carriers, and their tumors are mostly on the left side of the colon. According to the researchers, they may also have a better prognosis.

These findings led the researchers to suggest that “Ashkenazi BRCA 1 and 2 mutation carriers with colorectal cancer might have characteristics that are unique to them—that is, for example, a high rate of left-sided cancer, with what is called a mucinous histology, and accompanied by anal cancer.” For that reason, treatment may require different approaches.

The study is highlighted in the January 10, 2018, issue of European Journal of Human Genetics. 

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More